Results 141 to 150 of about 26,835 (181)

In long-lasting cellular stress phases of melanoma cells, stress granules are dissolved by HSP70. [PDF]

Cell Mol Life Sci
Staebler S, Pieger K, Perl J, Stieglitz D, Thongmao A, Schneider N, Bosserhoff AK, Kuphal S.   +7 more
europepmc   +1 more source

Exploring the role of the key gene TNFAIP3 between periodontitis and influenza A through bioinformatic analysis and molecular docking. [PDF]

PLoS One
Xu M, Shi J, Wang Y, Wu J, Yang Q, Chen W, Li Y, Zhang L, Liu X, Ren F, Wu Y, Ye L, Li X, Xu K.   +13 more
europepmc   +1 more source

Adipocyte-Derived Extracellular Vesicles Endow Melanoma Cells with Stem-like Traits via PGC-1α-Mediated Mitochondrial Reprogramming. [PDF]

Antioxidants (Basel)
Giannitti G, Marchesi S, Garavaglia R, Preosto I, Carollo E, Sartori P, Fontana F.   +6 more
europepmc   +1 more source

Multi-tyrosine kinase inhibitors: exploring immunomodulatory effects on various immune cell types in cancer. [PDF]

Cancer Cell Int
Keshavarz F, Soltanshahi M, Ayadilord M, Mortazavi F, Shabani M, Jalali SA.   +5 more
europepmc   +1 more source

COLUMBUS part 1-7-year results for encorafenib and binimetinib in BRAF V600-mutant melanoma. [PDF]

Future Oncol
Schadendorf D.
europepmc   +1 more source

Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma. [PDF]

Cancer Cell Int
Shi W, Tang H, Tong L, Song P, Huang Y, Wan Z, Huang G, Liu Q, Zhan Z, Zhou Y, Li Y, Wen J, Tang B, Duan W, Ding J, Li X, Xie H.   +16 more
europepmc   +1 more source

Combining Molecular Dynamics and Machine Learning to Predict Drug Resistance Causing Variants of BRAF in Colorectal Cancer. [PDF]

Molecules
Xie L, Lockhart C, Klimov DK, Jafri MS.
europepmc   +1 more source

Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patients. [PDF]

EMBO Mol Med
Weidele K, Werno C, Treitschke S, Botteron C, Hoffmann M, Scheitler S, Wöhrl L, Czyz Z, Feliciello G, Weber F, Ravikumar Varadarajan A, Warfsmann J, Materna-Reichelt S, Katzer M, Schreieder L, Mohammadi P, Hosseini H, Honarnejad K, Haferkamp S, Werner-Klein M, Klein CA.   +20 more
europepmc   +1 more source

Efficacy and safety of Dabrafenib in Erdheim-Chester disease. [PDF]

Ann Hematol
Liu ZZ, Liu WT, Miao HL, Chang L, Lang M, Lin H, Duan MH, Cao XX.   +7 more
europepmc   +1 more source

BRAF V600E in thyroid cancer: navigating prognostic uncertainty and therapeutic opportunity. [PDF]

Eur Thyroid J
Riesco-Eizaguirre G.
europepmc   +1 more source